Fabric Genomics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Fabric Genomics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013943
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fabric Genomics Inc (Fabric), formerly Omicia Inc is a healthcare solutions provider that offers genome analysis services. The company provides solutions for researchers and clinicians to analyze genomes and disease-causing variants and genes. Its products include opal software and standalone software. Fabric’s opal software offers opal clinical, opal research, opal in silico panels, and opal clinical trials. Omicia’s opal clinical software interprets and reports platform for clinical testing on targeted gene panels, exomes and whole genomes. The company’s VAAST is a disease gene finder and variant scoring algorithm used in academic and clinical institutions. It serves commercial clinical laboratories, country sequencing programs, hospital core labs, and research institutions. Omicia is headquartered in Oakland, California, the US.

Fabric Genomics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fabric Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Fabric Genomics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Omicia Raises US$7 Million In Series A Financing Round 11
Partnerships 12
Edico Genome Enters Into Partnership With Fabric Genomics 12
Fabric Genomics Enters into Agreement with ITTM 13
Real Time Genomics Enters Into Technology Integration Agreement With Omicia 14
Spiral Genetics Enters Into Agreement With Omicia To Analyze Genomes And Prioritize Disease-Causing Variants 15
Licensing Agreements 16
Omicia Enters Into Licensing Agreement With University of Utah Health Sciences 16
Fabric Genomics Inc – Key Competitors 17
Fabric Genomics Inc – Key Employees 18
Fabric Genomics Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Mar 03, 2016: Omicia Announces Appointment of Matt Tindall as Chief Executive Officer 20
Product News 21
Mar 09, 2016: Omicia Implements ACMG Variant Scoring and Classification Guidelines to Drive Clinical NGS Report Consistency and Throughput 21
Other Significant Developments 22
Mar 21, 2017: Omicia Rebrands as Fabric Genomics; Launches New End-to-End Computational Genomics Platform 22
Oct 17, 2016: Omicia Delivers Clinical Reports for 100,000 Genomes Project Main Program 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fabric Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fabric Genomics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Fabric Genomics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Omicia Raises US$7 Million In Series A Financing Round 11
Edico Genome Enters Into Partnership With Fabric Genomics 12
Fabric Genomics Enters into Agreement with ITTM 13
Real Time Genomics Enters Into Technology Integration Agreement With Omicia 14
Spiral Genetics Enters Into Agreement With Omicia To Analyze Genomes And Prioritize Disease-Causing Variants 15
Omicia Enters Into Licensing Agreement With University of Utah Health Sciences 16
Fabric Genomics Inc, Key Competitors 17
Fabric Genomics Inc, Key Employees 18
Fabric Genomics Inc, Subsidiaries 19

★海外企業調査レポート[Fabric Genomics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析
    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Natera Inc (NTRA)-医療機器分野:企業M&A・提携分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Cosmo Oil Co Ltd:企業の戦略的SWOT分析
    Cosmo Oil Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Nitori Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Nitori Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nitori Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kenya Electricity Generating Co Ltd (KGEN):企業の財務・戦略的SWOT分析
    Kenya Electricity Generating Co Ltd (KGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Bio Techne Corp (TECH):医療機器:M&Aディール及び事業提携情報
    Summary Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoa …
  • Immatics Biotechnologies GmbH:企業の戦略的SWOT分析
    Immatics Biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Lattice Semiconductor Corp (LSCC):企業の財務・戦略的SWOT分析
    Lattice Semiconductor Corp (LSCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • LPL Financial Holdings Inc (LPLA):企業の財務・戦略的SWOT分析
    LPL Financial Holdings Inc (LPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Geberit Ag:企業の戦略・SWOT・財務分析
    Geberit Ag - Strategy, SWOT and Corporate Finance Report Summary Geberit Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vermilion Energy Inc (VET):石油・ガス:M&Aディール及び事業提携情報
    Summary Vermilion Energy Inc (Vermilion) is an oil and gas company that offers exploration and production services. The company is an oil and gas producer in Alberta. It offers production programs focusing on acquisition, exploration, development and optimization in North America, Europe and Austral …
  • Union Jack Oil plc (UJO):企業の財務・戦略的SWOT分析
    Summary Union Jack Oil Plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole …
  • Heat Biologics Inc (HTBX)-製薬・医療分野:企業M&A・提携分析
    Summary Heat Biologics Inc (Heat Biologics) is an immuno-oncology company that develops novel therapies to activate patient’s immune system against cancer. The company develops immune pan-antigen cytotoxic therapy, which is a therapeutic vaccine used in the treatment of cancer and infectious disease …
  • Siemens AG (SIE):製薬・医療:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …
  • Tanzania Electric Supply Co Ltd:企業の戦略的SWOT分析
    Tanzania Electric Supply Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Dentsply Sirona Inc (XRAY):企業の財務・戦略的SWOT分析
    Dentsply Sirona Inc (XRAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Simpson Manufacturing Co Inc (SSD):企業の財務・戦略的SWOT分析
    Simpson Manufacturing Co Inc (SSD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Novanta Inc (NOVT):企業の財務・戦略的SWOT分析
    Novanta Inc (NOVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆